Welcome! Login | Register
 

RI’s First Annual Mind Body Spirit Expo Arrives—Rhode Island's first ever Mind Body Spirit Expo…

Side of the Rhode: Who’s Hot and Who’s Not?—Side of RI: Who's Hot and Who's Not?

Friday Financial Five – October 31st, 2014—Two positive developments this week include

5 Live Music Musts - October 31, 2014—There’s something just a little frightening about all…

Finneran: Too Old, Too White, Too Male To Understand….—why parents would allow their young children---girls specifically---to…

The Cellar: Wines That Get Better With Time—Invest now and enjoy later...

The Scoop: Smith Blasts Paiva-Weed on False Allegations, Elorza Questions Cianci’s Apology, and More—Welcome back to The Scoop, the 4 p.m.…

FM Global Pledges $1 million to URI’s Proposed Engineering Facility—FM Global has pledged $1 million to support…

Brian Bishop: A Turning Point in RI: Will Voters Approve a Constitutional Convention?—It is OSTPA’s contention that the decision to…

Mark McKenney: Providence Community Library is Too Important To Underfund—This summer, Providence Community Library celebrated its fifth…

 
 

NEW: Women & Infants Physician Sandra Carson Earns FDA Award

Friday, May 18, 2012

 

Women & Infants physician Sandra A. Carson receives an honor from the FDA.

The United States Food and Drug Administration (FDA) recently honored Sandra A. Carson, MD, with an FDA Advisory Committee Distinguished Service Award for 2011.

Dr. Carson, who is medical director of the Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and director of the hospital’s Division of Reproductive Endocrinology and Infertility, served as a member and chair of the Advisory Committee for Reproductive Health Drugs for several years.

Sandra Carson: "A powerful force"

“When Dr. Carson arrived at Women & Infants, we knew she was a powerful force in the field of reproduction and infertility in the world,” says Constance Howes, president and CEO of Women & Infants. “Since then, she has continued to amaze with her dedication to the couples struggling with infertility, at both a local, national and international level. This award reflects the depth of her commitment to her field.”

The FDA maintains a host of advisory committees, including those focused on various categories of drugs. The committee members, who are chosen by the FDA commissioner, provide independent opinions and recommendations on applications to market new drugs and on FDA policies. The FDA generally follows the advisory committee’s recommendations but it is not bound to do so.

The Advisory Committee for Reproductive Health Drugs is charged with reviewing and evaluating data on the safety and effectiveness of marketed and investigational human drugs for use in the practice of obstetrics, gynecology, and related subspecialties, and make appropriate recommendations to the Commissioner of Food and Drugs.

Top doc in the US

Dr. Carson, a reproductive endocrinologist, is on the U.S. News & World Report’s Top Doctors list as being among the top 1% in the nation in her specialty. A professor at The Warren Alpert Medical School of Brown University, Dr. Carson was part of the Brown-Women & Infants research team that in 2010 invented the world’s first artificial human ovary, a new tool in fertility research. It can mature human eggs in the laboratory and could help preserve the fertility of women facing chemotherapy or other treatments.

For more Health coverage, don't miss GoLocalTV, fresh every day at 4pm and on demand 24/7, here.

 

Related Articles

 

Enjoy this post? Share it with others.